Disruptive psychopharmacology / Frederick S. Barrett, Katrin H. Preller, editors.
Barrett, Frederick S. editor.; Preller, Katrin H. editor.
2022
RM315
Available Online

Linked e-resources

Linked Resource Online Access
Concurrent users Unlimited
Authorized users Authorized users
Document Delivery Supplied Can lend chapters, not whole ebooks

Details

Title Disruptive psychopharmacology / Frederick S. Barrett, Katrin H. Preller, editors.
ISBN 9783031121845 (electronic bk.)
3031121848 (electronic bk.)
303112183X
9783031121838
DOI https://doi.org/10.1007/978-3-031-12184-5
Publication Details Cham, Switzerland : Springer, 2022.
Language English
Description 1 online resource.
Item Number 10.1007/978-3-031-12184-5 doi
Call Number RM315
Dewey Decimal Classification 615.7/8
Summary Psychedelic therapies are gaining traction as potential treatments for a wide range of indications, but the structure and delivery of psychedelic therapies are a sharp departure from more traditional models of psychotherapy and pharmacotherapy for psychiatric and other medical disorders. This may be critical to their success. The current volume provides a comprehensive review of the state of the science of psychedelic therapies, including discussion of models and approaches to psychedelic therapies as well as the current status of safety and efficacy data for mood, substance use, trauma, obsessive-compulsive, neurodevelopmental, neurodegenerative disorders, neurological, and inflammatory disorders.
Access Note Access limited to authorized users.
Source of Description Online resource; title from PDF title page (SpringerLink, viewed September 1, 2022).
Added Author Barrett, Frederick S. editor.
Preller, Katrin H. editor.
Series Current topics in behavioral neurosciences ; v. 56.
Available in Other Form Print version: 9783031121838
Linked Resources Online Access
Record Appears in Online Resources > Ebooks
All Resources
Dosing psychedelics and MDMA
Psychedelic Group Therapy
Set and Setting: Aesthetic experiences and their contribution to psychedelic therapies
Psychedelic-Assisted Therapy for Social Adaptability in Autistic Adults
Foundations for Training Psychedelic Therapists
Ayahuasca for the Treatment of Depression
Psilocybin for the Treatment of Depression
Ketamine for the Treatment of Depression
The Potential of Psychedelics for End of Life and Palliative Care
Psychedelic-Assisted Therapy for Addiction and Potential Mechanisms of Action
Psilocybin for Tobacco Use Disorder
Psychedelic Drugs as Anti-Inflammatory Agents
Psilocybin for the Treatment of Obsessive-Compulsive Disorder
Psilocybin for the Treatment of Headache and Pain Disorders
Psilocybin for the Treatment of Neurodegenerative Disorders
Psilocybin for Trauma-Related Disorders.

Browse Subjects

Show more subjects...

Statistics

from
to
Export